themselves, and the prices of drugs are going up 2 to 3 times the rate of general inflation in the economy. they went up about 8% or 9% for brand-name and specialty drugs. something's broken in a market where a drug can go up that much in price. i don't call it competition. - is there a regulatory role for the ftc, the trade commission, or fda to get involved in these issues that people are facing right now on drug pricing? - and again, i think drug prices are ultimately an insurance issue. do you have insurance that will allow you to purchase that with the kind of discounts, bulk discounts your employer has? - as you know, a lot of plans don't even have prescription services, or you pay more, you know, for a prescription. in other words, some insurance plans, they're not an automatic part of your health insurance, so... - the vast majority of health plans in america cover prescription drugs. now if you look at how the market's acting, we're pretending that there's lots of prescription branded drug power in the market, we shouldn't be seeing the shift we're seeing from branded to generics,